‌

US Patent 11607439 Natural drugs for the treatment of inflammation and melanoma

Patent 11607439 was granted and assigned to Herbalife on March, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

‌

Herbalife International Inc

Current Assignee

Herbalife

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

116074390

Patent Inventor Names

Bruce L. Howe0

Date of Patent

March 21, 2023

Patent Application Number

169837150

Date Filed

August 3, 2020

Patent Primary Examiner

‌

Michael V Meller

The invention is directed to natural drug compositions comprising turmeric, boswellia and ginger. Methods for the use of the inventive drug compositions in the treatment of inflammatory disorders and melanoma are within the scope of the invention.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11607439 Natural drugs for the treatment of inflammation and melanoma

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API